Drug intelligence / Profile preview

(R)-alpha lipoic acid

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

(R)-alpha lipoic acid is the naturally occurring enantiomer of alpha-lipoic acid, a vitamin-like antioxidant and essential cofactor for mitochondrial enzyme complexes involved in energy production and the catabolism of alpha-keto acids and amino acids. It acts as a potent antioxidant both intra-and extracellularly by scavenging reactive oxygen species and regenerating other antioxidants. The compound is used primarily as a dietary supplement for its antioxidant properties and has been studied for use in diabetic neuropathy, metabolic disorders, obesity management, hyperlipidemia, cancer adjunct therapy, liver ailments, and HIV-related conditions. In Germany it is approved as a drug for diabetic neuropathy[5][8][9][10].

Brand names
ThioctacidThioctan
Other names
RLA1,2-dithiolane-3-valeric acid5-(1,2-dithiolan-3-yl) valeric acid6,8-thioctic acid
02

Targets

OGDH (Dihydrolipoamide S-succinyltransferase)DBT (Branched-chain alpha-keto acid dehydrogenase E2 component)DLD (Dihydrolipoamide dehydrogenase)DLAT (Dihydrolipoamide S-acetyltransferase)Complex II (Succinate dehydrogenase)

Beyond the preview

Go deeper on (R)-alpha lipoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (R)-alpha lipoic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call